Get faster, more accurate results with behavioral health software. 

The PHQ9 and GAD7, which were not intended to screen for or diagnose mental health disorders, contribute to the misdiagnosis of major depressive disorder 65.9% and generalized anxiety disorder 71% of the time. And the more comprehensive SCID-5 often used in research is time-consuming and inefficient to administer, especially on paper. 

In all other areas of healthcare there is a protocol for diagnosing and treating illness. In mental health, there is no such consistent or comprehensive process to guide providers through evidence-based care or researchers through participant selection for trials/studies. 

Manual and paper-based mental health evaluations often introduce bias, scoring errors, and inconsistency for healthcare providers, therapists, and researchers. This leads to variations in care and selection of the wrong trial/study participants. 

Misdiagnosis and missed diagnoses waste time and money for providers and are costly to patients who may wait as long as 11 years for a correct diagnosis. For researchers, the wrong diagnosis could mean the wrong participants, which puts a trial/study at risk. 

Without the ability to easily interact with patients or participants outside the office, many organizations simply have no idea if a patient gets better, or if a trial/study participant follows the study protocol. And an inability to collect data during treatment or a trial makes measurement-based care, quality improvement and regulatory compliance difficult.